Loading...
Reliance On Single Therapy Will Trigger Competition Yet Secure Recovery
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
107.2%7D
-0.4%1Y
107.2%7D
-0.4%You can edit this narrative until Aug 28 10:16 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 28 10:16 PM. Then, changes will post as Updates.